Brain Tumor Clinical Trials

Find Brain Tumor Clinical Trials Near You

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This pilot and feasibility study aims to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, to offer an intraoperative image-guided solution for lesion-specific surgical resection to impact clinical outcome. Should this imaging approach help isolate specific lesions and prevent surgical resection of normal pituitary tissue in this first-in-humans study, then the results will provide clinical data for a much larger multi-center clinical trial.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Diagnosis of Cushing disease or required resection for non-corticotroph adenomas

• Agree to transsphenoidal resection.

• Patients undergoing any pituitary surgery with the study designated neurosurgeons.

• Patients whose procedures require the use of an intra-operative BK ultrasound without contrast.

Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Neurologic Surgery Research Department
Riess.Lesley@mayo.edu
507-293-7354
Backup
Ian Mark, MD
507-284-3211
Time Frame
Start Date: 2024-06-19
Estimated Completion Date: 2027-01
Participants
Target number of participants: 110
Treatments
Contrast
Patients who are scheduled for transsphenoidal surgical resection for Cushing disease or transsphenoidal resection for non-corticotroph adenomas.
Non-Contrast
Patients who are scheduled for a pituitary surgical procedure requiring an intra-operative ultrasound without contrast.
Sponsors
Leads: Mayo Clinic
Collaborators: GE Healthcare, Lantheus Medical Imaging, American Society of Head and Neck Radiology

This content was sourced from clinicaltrials.gov